Motexafin gadolinium
3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium(3+);diacetate
Molecular Identity
Motexafin gadolinium
3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium(3+);diacetate
PubChem CID: 158385
2D Structure
Properties
C52H72GdN5O14
Molecular Formula
1148.40
Molecular Weight
g/mol
1148.4317
Exact Mass
Da
245
TPSA
May have limited oral absorption
2
H-Bond Donors
19
H-Bond Acceptors
1900
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(12)
Motexafin gadoliniumGadolinium texaphyrinXcytrinPCI-0120246252-06-23-[4,5-Diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium(3+);diacetate0BG5NE3APZMotexafin gadolinium anhydrousSCHEMBL29355268MOTEXAFIN GADOLINIUM [MI]DB05428Q11786072
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Motexafin gadolinium
Loading drug network...